Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Sigyn Therapeutics Shareholders Equity (Quarterly): -3.412M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.412M |
| September 30, 2023 | -3.576M |
| June 30, 2023 | -3.042M |
| March 31, 2023 | -2.346M |
| December 31, 2022 | -1.903M |
| September 30, 2022 | -1.742M |
| June 30, 2022 | -1.183M |
| March 31, 2022 | -0.7316M |
| December 31, 2021 | -0.2646M |
| September 30, 2021 | 0.3582M |
| June 30, 2021 | 0.9771M |
| March 31, 2021 | -0.0803M |
| December 31, 2020 | 0.0992M |
| September 30, 2020 | -2.819M |
| June 30, 2020 | -2.669M |
| March 31, 2020 | -2.570M |
| December 31, 2019 | -2.461M |
| September 30, 2019 | -3.917M |
| Date | Value |
|---|---|
| June 30, 2019 | -3.778M |
| March 31, 2019 | -3.661M |
| December 31, 2018 | -3.715M |
| September 30, 2018 | -2.682M |
| June 30, 2018 | -2.464M |
| March 31, 2018 | -2.401M |
| December 31, 2017 | -2.094M |
| September 30, 2017 | -2.988M |
| June 30, 2017 | -1.711M |
| March 31, 2017 | -1.220M |
| December 31, 2016 | -0.6918M |
| September 30, 2016 | -1.242M |
| June 30, 2016 | -0.9752M |
| March 31, 2016 | -0.4148M |
| December 31, 2015 | -1.181M |
| September 30, 2015 | 0.022M |
| December 31, 2014 | 0.0994M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.917M
Minimum
Sep 2019
0.9771M
Maximum
Jun 2021
-1.845M
Average
-2.346M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.3218M |
| Total Liabilities (Quarterly) | 3.734M |